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Synopsis 16 
Objectives  17 
We aimed to explore the phenomenon of phenotypic resistance to anti-mycobacterial 18 
antibiotics and to determine whether this was associated with cell age or presence of lipid 19 
bodies. 20 
Methods 21 
The accumulation of lipid body positive cells (lipid rich- LR) was followed using cell staining 22 
and flow cytometry. LR cells of M. smegmatis, M. marinum, M. fortuitum and BGC were 23 
separated from non-lipid body containing cells (lipid poor- LP) and their MBC determined.  24 
We also compared the MBC of LR and LP from “old” and “young” cultures. 25 
Results 26 
 The LR cells of all species were more resistant to antibiotics than LP cells. For 27 
Mycobacterium bovis (BCG) the susceptibility ratios were as follows; Rifampicin-5X, 28 
isoniazid-16.7X, ethambutol-5X, ciprofloxacin-5X. Phenotypic resistance was found in LR 29 
cells irrespective of cell age. 30 
Conclusions 31 
We have shown that phenotypic antibiotic resistance is associated with the presence of lipid 32 
bodies irrespective of cell age.  These data have important implications for our 33 
understanding of relapse in mycobacterial infections. 34 
  35 
Introduction 36 
Mycobacteria tuberculosis (MTB) causes chronic pulmonary infection and considerable 37 
morbidity, mortality and economic loss internationally. 1,2  The currently recommended drug 38 
regimen duration is for six months, although for more than 80% of patients this is too long. 3  39 
It has proved impossible to identify the patients for whom shorter regimens would be 40 
effective. 4 41 
 42 
A ‘dormant’ cell state where the bacteria are not actively dividing is often postulated to be 43 
responsible for relapse. 5,6  Deb et al identify cells that are ‘lipid loaded’ and postulate that 44 
they are in a dormant or quiescent state.  Late stationary phase cultures of mycobacteria 45 
are known to be more resistant to drugs 7 and the concentration of drug required to clear all 46 
bacteria (the MBC- minimum bactericidal concentration) rises significantly. 8  Older cells 47 
express lipid bodies 9-12 and it is assumed they are responsible for the phenotypic resistance 48 
found.  It is uncertain whether phenotypic resistance is associated with cell age or with the 49 
presence of lipid bodies.  In this paper we address this question using innovative methods to 50 
separate LR from LP cells.   51 
  52 
Methods 53 
Bacteria and culture.  54 
Isolates of M. smegmatis (NCTC 8159), M. fortuitum (CIP 104534), M. marinum (M-strain) 55 
and M. bovis (BCG)(NCTC 5692) were incubated in batch cultures in sealed tubes in 56 
Middlebrook 7H9 (Fluka) with 0.05% Tween (Sigma Aldrich) (37°C for all species but M. 57 
marinum which was incubated at 30°C) for the appropriate duration.  Viable count was 58 
determined by a modified Miles and Misra method as described previously. 13 59 
 60 
Buoyant density separation 61 
An aliquot (1mL) of bacterial cells were harvested from culture and washed three times by 62 
centrifugation (20,000g for 3 minutes) with sterilise water (0.22um filters, Millipore). Cells 63 
were re-suspended in 100µL of 75% D2O 25% dH2O (D2O from Sigma Aldrich), sealed and 64 
equilibrated over 24 hours without agitation. 100µL of cell suspension from within 1mm of 65 
the meniscus was removed using a modified P200 pipette. 100µL of cell from within 1mm of 66 
the bottom of the tube was removed while bubbling air to prevent cells from other layers 67 
entering the pipette tip. 68 
  69 
Staining 70 
Mycobacterial cells were stained with (1mg/mL) Nile Red (Sigma Aldrich) at room 71 
temperature with constant agitation for 20 minutes. The samples were washed with 100% 72 
ethanol and again with PBS and an aliquot (10µL) was spotted on to a clean glass slide and 73 
heat-fixed.  Bacterial preparations were viewed by fluorescence microscopy at 100X (Leica 74 
DM5500) (excitation; 480/40, 540/40. Emission 527/30, 645/75).   75 
 76 
Flow cytometry 77 
Flow cytometry was carried out on a Millipore Guava easyCyte™ HT. Cells were stained with 78 
Nile Red as above and loaded into a round-bottomed 96 well plate. This was loaded into the 79 
flow cytometer which excited the samples at 488nm and read the samples at 525/30nm and 80 
690/50nm.  81 
 82 
Old Lipid-rich cells versus young lipid-rich cells 83 
Samples grown to late stationary phase were designated ‘old’. Mid exponential cultures 84 
were designated ‘young’.  All samples were taken at the same time points relative to growth 85 
rate.  Samples were separated into LR and LP fractions and treated with each of four 86 
antibiotics; ciprofloxacin (Sigma), rifampicin (Sigma), Isonaizid (Sigma) and ethambutol 87 
(Sigma). The antibiotics were administered at concentrations from below the MBC to >10x 88 
the MBC (See Table 1).  Bacteria were incubated with the drug suspended in PBS overnight 89 
(~16hours). The 96-well plates were centrifuged at 3000RPM for 10 minutes and the drug-90 
containing supernatant removed. Middlebrook 7H9 media was then added and the plates 91 
were incubated for a further 72 hours. The MBC was defined as the lowest concentration 92 
that produced a sterile sample. Constant and equal inoculum sizes (300-700 cells) were 93 
maintained by on-site growth analysis in parallel. 94 
 95 
Mixed cultures were prepared identically as above but without the separation step. 96 
Experiments were conducted as either MBC90 or MBC trials. Results were collected with the 97 
same methodology as above.  98 
 99 
 100 
Results 101 
 102 
Accumulation of lipid bodies 103 
The accumulation of cells exhibiting lipid bodies as detected by flow cytometry was 104 
illustrated for all four species studied in Figure 1.  After approximately 100 hours in culture 105 
M. smegmatis, M. fortuitum and M. marinum reached stationary phase whereas BCG 106 
reached stationary phase at approximately 150 hours. It was possible to detect lipid bodies 107 
in increasing numbers after these cultures had reached stationary phase. These data are 108 
confirmed by microscopic studies performed in parallell (data not shown). M. smegmatis, 109 
M. fortuitum and  M. marinum all grew at approximately the same speed to approximately 110 
the same density and by 100 hours contained LR cells. BCG grew more slowly but to a 111 
similar density by the time it reached stationary phase, approximately 150 hours. 112 
Interestingly the BCG culture seemed to contain a low level of detectable LR cells from 113 
around 120 hours when there was a small plateau in the growth of the bacteria, this 114 
coincides with the first detectable LR cells in the culture and the number of LR cells rose 115 
after approximately 160 hours.  116 
 117 
In both M. smegmatis and BCG cultures approximately 1000 LR events were detected per 118 
5000 events when the experiment was terminated.  In M. marinum and  M. fortuitum 119 
cultures, approximately 2000 LR events were detected. The level of LR cells began to rise 120 
earliest in the M. marinum culture at 76 hours, followed by the M. fortuitum culture at 80 121 
hours and then M. smegmatis at 96 hours. In all cultures LR cell levels began to rise only 122 
after stationary phase had been reached. In all cases (excepting BCG) the level of red 123 
fluorescence did not track well with the cfu counts seeming to peak much later than the cfu 124 
counts. In BCG the level of red fluorescence was a good measure of bacterial biomass. In the 125 
M. marinum culture at the final timpoint (104 hours) the quantity of green fluorescence 126 
detected was higher than that of the red fluorecsence.  127 
 128 
 Susceptibility of separated cultures 129 
The susceptibilty of purified LR and LP  cells was tested for four antibiotics in all four species. 130 
We showed that the antibiotic concentration  required to sterilise a culture of LR cells was 131 
higher than that required to sterilise a culture containing the same number of LP cells Table 132 
1. When the LR cells were analysed there is a significant increase in the concentration of 133 
drug required to kill all of the cells.    134 
 135 
To address the question of whether the relative resistance demonstrated is a function of 136 
culture age or is associated with the presence of lipid bodies we separated LR from young 137 
cultures and LP cells from old cultures.  The MBCs for the separated old and young cultures 138 
are illustrated in in figure 2 and demonstrate that, LR cells of all species and of all ages 139 
require a higher concentration of antibiotic to kill them compared with the LP cells whether 140 
young or old.    141 
 142 
Discussion 143 
Understanding how phenotypic resistance arises in mycobacteria is important if we are to 144 
improve treatments against tuberculosis.  This is critical with recent treatment trials failing 145 
to show non-inferiority due to an excess of relapse. 14 We have addressed this question by 146 
investigating the relationship between the presence of lipid bodies in mycobacterial cells 147 
and phenotypic resistance to antibiotics.  148 
We have shown that cells from old cultures are more resistant than exponentially growing 149 
cultures as has been described previously. 8,15 We have expanded this observation 150 
significantly by demonstrating that samples with >95% LR cells share this resistance pattern, 151 
whereas LP cells behave like the exponentially growing mixed cultures. 152 
 153 
As in vitro mycobacterial cultures grow and age the supernatant becomes more acidic. 16 If 154 
left unopened the level of oxygen available to the bacteria drops. 17 The quantity of 155 
nutrients available to the organism will also drop 18 and the population density of the 156 
bacteria obviously increases. In these circumstances bacteria are exposed to multiple 157 
stresses previously associated with the production of lipid bodies. 19-21 When LR and LP cells 158 
are separated we have shown that the individual drug susceptibilities are very different. In 159 
all cases it requires higher concentrations of drug to sterilise a culture of LR cells than the 160 
same number of LP cells. 161 
 162 
Our separation technique has allowed us to clarify the association of lipid bodies and 163 
phenotypic resistance. We have shown that lipid bodies are not only found in old or 164 
stressed cultures; it was possible to find LR cells in young cultures. This observation holds 165 
true for all four species tested.   Critically important is the lack of difference between old 166 
and young LR and LP cells (table 1). LR and LP cells reacted similarly to the drugs irrespective 167 
of whether they came from a young or an old culture. 168 
 169 
Our observations have important implications for the treatment of mycobacterial infections 170 
and such cells are found in patients with tuberculosis. 22  As the LR phenotype is associated 171 
with an increase in the minimal bactericidal concentration of between 3 and 40 times, it 172 
may come to provide the first evidence that such cells are difficult to eradicate. 173 
 174 
It is possible that the results we have obtained are influenced by the D2O separation 175 
technique.  Possibly some LR cells resuscitate and convert back to LP and some are stressed 176 
or naturally form lipid bodies during the incubation period but similar results were achieved 177 
with samples separated using D2O and a short centrifugation step (data not shown). 178 
 179 
In summary, we have shown that the important phenomenon of phenotypic antibiotic 180 
resistance is closely associated with the presence of lipid bodies.  The relative resistance 181 
exhibited by these cell types and their presence in lung lesions provides an insight into the 182 
challenges of eradicating such cells and preventing relapse. 183 
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  252 
Figure 1. Cultures of four mycobacterial species grown until levels of lipid bodies rose to 253 
detectable levels resulting from Nile Red staining seen in relation to the cfu count over 254 
time. The level of green fluorescence begins to rise after ~100 hours for M. smegmatis, M. 255 
fortuitum and M. marinum and after ~160 hours for BCG indicating a rise in lipid body 256 
formation and a possible downshift in metabolic function. Right hand Y axis is Log cfu/mL 257 
and left hand Y axis is flow cytometric events; number of detected particles.  258 
 259 
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 262 
 263 
 264 
 265 
 266 
 267 
 268 
Figure 2. A comparison of old and young LR and LP cells when separated showing that the 269 
age of the cell is irrelevant, the lipid body status is the deciding factor for antibiotic 270 
susceptibility. 271 
Quantity of drug required to kill all cells in culture 
 272 
Table 1. MBC for M. smegmatis, M. fortuitum, M. marinum and BCG for both LP and LR samples. LR samples required up to 40X more drug to 273 
be sterilised. Also shown; fold increases in the quantity of drug required to sterilise a culture of LR cells when compared to LP cells. 274 
 275 
 
 
 
 
 
Drugs 
LP MBC 
values for 
M. 
smegmatis 
(mg/L) 
LR MBC 
values for 
M. 
smegmatis 
(mg/L) 
Increase in 
drug 
concentrati
on required 
to clear LR 
cells (fold) 
LP MBC 
values for 
M. 
fortuitum 
(mg/L) 
LR MBC 
values for 
M. 
fortuitum 
(mg/L) 
Increase in 
drug 
concentrati
on required 
to clear LR 
cells (fold) 
LP MBC 
values for 
M. marinum 
(mg/L) 
LR MBC 
values for 
M. marinum 
(mg/L) 
Increase in 
drug 
concentrati
on required 
to clear LR 
cells (fold) 
LP MBC 
values for 
BCG (mg/L) 
LR MBC 
values for 
BCG (mg/L) 
Increase in 
drug 
concentrati
on required 
to clear LR 
cells (fold) 
Rifampicin 25 1000 40 50 1000 20 100 500 5 1 5 5 
Isoniazid 30 1000 33.3 50 1000 20 50 750 15 15 250 16.7 
Ethambutol 30 1000 33.3 na na na 10 150 15 50 250 5 
Ciprofloxacin 35 100 2.9 50 250 5 50 250 5 5 25 5 
